209 related articles for article (PubMed ID: 29271075)
1. Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.
Ali I; Slizgi JR; Kaullen JD; Ivanovic M; Niemi M; Stewart PW; Barritt AS; Brouwer KLR
Clin Pharmacol Ther; 2017 Dec; ():. PubMed ID: 29271075
[TBL] [Abstract][Full Text] [Related]
2. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
[TBL] [Abstract][Full Text] [Related]
3. Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression.
Clarke JD; Hardwick RN; Lake AD; Canet MJ; Cherrington NJ
J Pharmacol Exp Ther; 2014 Mar; 348(3):452-8. PubMed ID: 24403518
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.
Swift B; Yue W; Brouwer KL
Pharm Res; 2010 Sep; 27(9):1987-98. PubMed ID: 20652625
[TBL] [Abstract][Full Text] [Related]
5. Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin-drug interactions.
Lynch KD; Montonye ML; Tian DD; Arman T; Oyanna VO; Bechtold BJ; Graf TN; Oberlies NH; Paine MF; Clarke JD
Phytother Res; 2021 Jun; 35(6):3286-3297. PubMed ID: 33587330
[TBL] [Abstract][Full Text] [Related]
6. A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model.
Montonye ML; Tian DD; Arman T; Lynch KD; Hagenbuch B; Paine MF; Clarke JD
J Pharmacol Exp Ther; 2019 Nov; 371(2):385-393. PubMed ID: 31420525
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
[TBL] [Abstract][Full Text] [Related]
9. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
[TBL] [Abstract][Full Text] [Related]
10. Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [
Marie S; Hernández-Lozano I; Breuil L; Saba W; Novell A; Gennisson JL; Langer O; Truillet C; Tournier N
Pharmaceutics; 2020 May; 12(6):. PubMed ID: 32471244
[TBL] [Abstract][Full Text] [Related]
11. Imaging-Based Characterization of a
Marie S; Hernández-Lozano I; Breuil L; Truillet C; Hu S; Sparreboom A; Tournier N; Langer O
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34205780
[TBL] [Abstract][Full Text] [Related]
12. Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity.
Jilek JL; Frost KL; Jacobus KA; He W; Toth EL; Goedken M; Cherrington NJ
Acta Pharm Sin B; 2021 Dec; 11(12):3869-3878. PubMed ID: 35024313
[TBL] [Abstract][Full Text] [Related]
13. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Imaging Using
Marie S; Hernández-Lozano I; Le Vée M; Breuil L; Saba W; Goislard M; Goutal S; Truillet C; Langer O; Fardel O; Tournier N
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455390
[TBL] [Abstract][Full Text] [Related]
15. Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.
Loos NHC; Ferreira Martins ML; Rijmers J; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
Mol Pharm; 2024 Apr; 21(4):1952-1964. PubMed ID: 38423793
[TBL] [Abstract][Full Text] [Related]
16. Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist).
Sandoval P; Chuang BC; Fallon JK; Smith PC; Chowdhury SK; Griffin RJ; Xia CQ; Iwasaki S; Chothe PP
AAPS J; 2022 Sep; 24(6):99. PubMed ID: 36123502
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions.
Székely V; Patik I; Ungvári O; Telbisz Á; Szakács G; Bakos É; Özvegy-Laczka C
Eur J Pharm Sci; 2020 Aug; 151():105395. PubMed ID: 32473861
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease.
Vildhede A; Kimoto E; Pelis RM; Rodrigues AD; Varma MVS
Clin Pharmacol Ther; 2020 May; 107(5):1128-1137. PubMed ID: 31630405
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.
Dong J; Olaleye OE; Jiang R; Li J; Lu C; Du F; Xu F; Yang J; Wang F; Jia W; Li C
Br J Pharmacol; 2018 Sep; 175(17):3486-3503. PubMed ID: 29908072
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
